137 related articles for article (PubMed ID: 12867641)
1. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland.
Laukkanen P; Koskela P; Pukkala E; Dillner J; Läärä E; Knekt P; Lehtinen M
J Gen Virol; 2003 Aug; 84(Pt 8):2105-2109. PubMed ID: 12867641
[TBL] [Abstract][Full Text] [Related]
2. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.
Luostarinen T; af Geijersstam V; Bjørge T; Eklund C; Hakama M; Hakulinen T; Jellum E; Koskela P; Paavonen J; Pukkala E; Schiller JT; Thoresen S; Youngman LD; Dillner J; Lehtinen M
Int J Cancer; 1999 Mar; 80(6):818-22. PubMed ID: 10074912
[TBL] [Abstract][Full Text] [Related]
3. Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection.
Dillner J
J Clin Virol; 2000 Oct; 19(1-2):7-23. PubMed ID: 11091144
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas.
Sigstad E; Lie AK; Luostarinen T; Dillner J; Jellum E; Lehtinen M; Thoresen S; Abeler V
Br J Cancer; 2002 Jul; 87(2):175-80. PubMed ID: 12107839
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.
Touzé A; de Sanjosé S; Coursaget P; Almirall MR; Palacio V; Meijer CJ; Kornegay J; Bosch FX
J Clin Microbiol; 2001 Dec; 39(12):4344-8. PubMed ID: 11724843
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of human papillomavirus type 16 in pregnant women.
Hagensee ME; Slavinsky J; Gaffga CM; Suros J; Kissinger P; Martin DH
Obstet Gynecol; 1999 Nov; 94(5 Pt 1):653-8. PubMed ID: 10546705
[TBL] [Abstract][Full Text] [Related]
7. Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.
af Geijersstam V; Wang Z; Lewensohn-Fuchs I; Eklund C; Schiller JT; Forsgren M; Dillner J
Int J Cancer; 1998 May; 76(3):341-4. PubMed ID: 9579570
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of frequency human papillomavirus infections during pregnancy].
Szepietowska M; Słodziński H; Polz-Dacewicz M; Oleszczuk J
Ginekol Pol; 2002 Aug; 73(8):662-5. PubMed ID: 12369291
[TBL] [Abstract][Full Text] [Related]
9. Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study.
Louvanto K; Rintala MA; Syrjänen KJ; Grénman SE; Syrjänen SM
J Infect Dis; 2010 Aug; 202(3):436-44. PubMed ID: 20557239
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of human papillomavirus type 16 antibody seroconversion in young children.
Manns A; Strickler HD; Wikktor SZ; Pate EJ; Gray R; Waters D
Pediatr Infect Dis J; 1999 Sep; 18(9):833-5. PubMed ID: 10493350
[No Abstract] [Full Text] [Related]
11. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand.
Sukvirach S; Smith JS; Tunsakul S; Muñoz N; Kesararat V; Opasatian O; Chichareon S; Kaenploy V; Ashley R; Meijer CJ; Snijders PJ; Coursaget P; Franceschi S; Herrero R
J Infect Dis; 2003 Apr; 187(8):1246-56. PubMed ID: 12696004
[TBL] [Abstract][Full Text] [Related]
12. Pathobiology of human papillomavirus.
Prasad CJ
Clin Lab Med; 1995 Sep; 15(3):685-704. PubMed ID: 8542729
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus DNA in unselected pregnant and non-pregnant women.
Soares VR; Nieminen P; Aho M; Vesterinen E; Vaheri A; Paavonen J
Int J STD AIDS; 1990 Jul; 1(4):276-8. PubMed ID: 1965153
[TBL] [Abstract][Full Text] [Related]
14. Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.
Le Cann P; Chabaud M; Leboulleux D; Mougin C; Mayelo V; Legrand MC; Calvet C; Afoutou JM; Coll-Seck AM; Coursaget P
J Med Virol; 1995 Apr; 45(4):410-4. PubMed ID: 7545211
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities.
Rousseau MC; Villa LL; Costa MC; Abrahamowicz M; Rohan TE; Franco E
Sex Transm Dis; 2003 Jul; 30(7):581-7. PubMed ID: 12838088
[TBL] [Abstract][Full Text] [Related]
16. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
[TBL] [Abstract][Full Text] [Related]
17. Antibodies prevalence against HPV-6b and -16 recombinant fusion proteins in Korean patients with cervical neoplasia.
Park SN; Yoon HS; Choi YK; Choe IS; Chung RP; Chee YH; Namkoong SE; Kim SJ; Park JS
J Obstet Gynaecol (Tokyo 1995); 1995 Dec; 21(6):609-17. PubMed ID: 8640473
[TBL] [Abstract][Full Text] [Related]
18. A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children.
af Geijersstam V; Eklund C; Wang Z; Sapp M; Schiller JT; Dillner J; Dillner L
Int J Cancer; 1999 Feb; 80(4):489-93. PubMed ID: 9935145
[TBL] [Abstract][Full Text] [Related]
19. The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions.
Marais DJ; Vardas E; Ramjee G; Allan B; Kay P; Rose RC; Williamson AL
J Infect Dis; 2000 Oct; 182(4):1239-42. PubMed ID: 10979925
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of human papillomavirus antibodies in males and females in England.
Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
